Mindstate Design Labs has announced major news, receiving both FDA and European Medicines Agency (EMA) approval to commence human trials of its compound, MSD-001. This approval is a clinical validation for Mindstate’s advanced neurotech AI platform, Osmanthus, which specializes in the precision design of altered states of consciousness. According to Mindstate, MSD-001 is distinct from […] The post Mindstate Design Labs AI-Designed Trial Gets FDA Approval appeared first on Microdose ..read more

Psyence Biomed announces acquisition Clairvoyant Therapeutics and its Phase 2b trial The post Psyence Biomed Announces Acquisition of Psilocybin Drug Developer Clairvoyant Therapeutics appeared first on Microdose ..read more

Adamo Bioscience introduces the Adamo Method, a groundbreaking advancement in sexual medicine. Developed by Dr. Molly Maloof, Dr. Saida Desilets, and Aaron Michael, this innovative approach significantly improves sexual satisfaction and intimacy through practices involving breath, voice, touch, and movement. A recent clinical study, awaiting peer review, reveals that couples participating in the 8-week digital program experienced remarkable improvements in sexual satisfaction, communication, arousal, and orgasm quality. The Adamo Method shifts the focus from performance to embodied love, foste ..read more

In her latest book, "Inflamed: Theory," Kathryn A. Walker, CEO of Revitalist Lifestyle and Wellness Ltd., challenges traditional views on mental health. Available on Kindle and Amazon, this groundbreaking publication delves into the role of inflammation in mental health, the potential of ketamine and psychedelics in treatment, and the importance of holistic and innovative approaches. Walker's extensive experience in anesthesia and psychiatry brings a unique perspective, offering readers new hope and practical strategies for mental wellness. This book is a must-read for anyone seeking to unders ..read more

In recent years, the intersection of mental health practices and substance use has garnered significant attention, particularly among young adults navigating the complexities of modern life. The Herbal Heart Study, conducted by a multidisciplinary team from the University of Miami and affiliated institutions, explores the relationship between cannabis use and mindfulness in Southeast Florida. Preliminary findings reveal that cannabis users exhibit higher median scores for observing mindfulness compared to non-users, while non-users score higher on non-judgmental mindfulness. This study provide ..read more

Enveric Biosciences has announced promising preclinical results for their novel drug candidate, EB-003. The findings highlight the drug’s potential for oral administration and significant brain exposure in rodent models. These developments pave the way for accelerated clinical trials, with an IND application expected by the third quarter of 2025 and the first patient dosing by the end of the year. EB-003 is designed to treat severe mental health disorders without inducing hallucinations, offering a practical and patient-friendly treatment option. The post Enveric Biosciences Announces Promisin ..read more

CAMBRIDGE, Mass. – Enveric Biosciences (NASDAQ: ENVB) (“Enveric”), a biotechnology company dedicated to the development of novel neuroplastogens for the treatment of neuropsychiatric disorders, and Aries Science & Technology (“Aries”), a developer of encapsulation technologies, today announced a licensing agreement for the clinical development of Enveric’s patented radiation dermatitis topical product. Radiation dermatitis is a side effect of radiation treatment that impacts roughly two million cancer patients per year and has a market opportunity estimated at $400 million annual ..read more

Ketamine clinics have emerged as a groundbreaking solution for treatment-resistant depression and other mental health conditions. By leveraging the unique properties of ketamine, these clinics offer hope to patients who have not responded to traditional therapies. However, the integration of immersive technologies like SoundSelf can further enhance the efficacy of ketamine treatments. SoundSelf, an immersive biofeedback and neuro-stimulation technology, provides an adjunctive intervention that can significantly benefit patients undergoing ketamine therapy. This article explores the reasons why ..read more

In the realm of mental health care, few names resonate as strongly as Kathryn A. Walker. As a pioneering psychiatrist, anesthesia provider, and the visionary founder of Revitalist, Walker is reshaping the mental health landscape with her relentless pursuit of innovative treatments. Over the past six years, she has been at the forefront of mental health revolution, particularly in the application of ketamine treatments. Her latest achievement, the development of Kate NeuroPsych, an AI bot designed to streamline patient intake for ketamine and psychedelic therapies, marks a significant milestone ..read more

As the field of psychedelic therapy gains recognition and acceptance, a new avenue of opportunity is emerging for mental healthcare professionals. Over the past 70 years, psychedelic-assisted therapy has demonstrated safety and efficacy in Europe and North America, paving the way for a future where these treatments become more mainstream. As society increasingly embraces psychedelics, the demand for trained psychedelic therapists is expected to surge. This article delves into the evolving landscape of psychedelic therapist training, addressing essential questions and providing insights from ex ..read more